Literature DB >> 16523231

Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases.

Beatrix Feigl1, Brian Brown, Jan Lovie-Kitchin, Lawrence Lee.   

Abstract

PURPOSE: To monitor retinal function after multiple laser treatments by photodynamic therapy (PDT) with the multifocal electroretinogram (mfERG) in age-related macular degeneration (AMD).
METHODS: Five eyes of five subjects with AMD were investigated before the first and 1 month after each of three PDT treatments. Function was assessed using the cone- and rod-mediated mfERG, high-contrast distance visual acuity, central visual fields and contrast sensitivity. For each subject the local first-order mfERG results before treatment were used as a template and fitted against the local post-treatment results (Matlab, Mathworks).
RESULTS: We found transient reduction of the cone- and rod-mediated amplitudes between the first and second treatments but stable or improved mfERG function in four of five eyes for the cone-mediated mfERG and in all eyes for the rod-mediated mfERG after three treatments. Visual acuities and contrast sensitivities remained stable between treatments in four and two eyes respectively, whereas visual fields showed substantially higher mean defects in two subjects after all treatments.
CONCLUSION: As found in previous studies of the cone-mediated mfERG after one PDT treatment, objective function was stabilized after multiple treatments in this case report. Similarly, although poor at baseline, rod-mediated function was not further compromised. Transiently reduced amplitudes after 1 month possibly reflected choroidal hypoperfusion. A larger sample size is needed to confirm if additional evaluation using electrophysiological criteria might be helpful in re-treatment decisions during PDT.

Entities:  

Mesh:

Year:  2006        PMID: 16523231     DOI: 10.1007/s10633-005-5319-7

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  48 in total

Review 1.  Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization.

Authors:  U Schmidt-Erfurth
Journal:  Semin Ophthalmol       Date:  1999-03       Impact factor: 1.975

2.  [Testing central retinal function with multifocal electroretinography before and after photodynamic therapy].

Authors:  K Rüther; K Breidenbach; R Schwartz; A Hassenstein; G Richard
Journal:  Ophthalmologe       Date:  2003-06       Impact factor: 1.059

3.  Cone- and rod-mediated multifocal electroretinogram in early age-related maculopathy.

Authors:  B Feigl; B Brown; J Lovie-Kitchin; P Swann
Journal:  Eye (Lond)       Date:  2005-04       Impact factor: 3.775

4.  Atypical multifocal ERG responses in patients with diseases affecting the photoreceptors.

Authors:  V C Greenstein; K Holopigian; W Seiple; R E Carr; D C Hood
Journal:  Vision Res       Date:  2004-11       Impact factor: 1.886

5.  Monitoring retinal function in early age-related maculopathy: visual performance after 1 year.

Authors:  B Feigl; B Brown; J Lovie-Kitchin; P Swann
Journal:  Eye (Lond)       Date:  2005-11       Impact factor: 3.775

6.  The design and use of a new near-vision chart.

Authors:  I L Bailey; J E Lovie
Journal:  Am J Optom Physiol Opt       Date:  1980-06

7.  Photodynamic effects on choroidal neovascularization and physiological choroid.

Authors:  Ursula Schmidt-Erfurth; Stephan Michels; Irene Barbazetto; Horst Laqua
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

8.  The nature and extent of retinal dysfunction associated with diabetic macular edema.

Authors:  V C Greenstein; K Holopigian; D C Hood; W Seiple; R E Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

9.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

10.  Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.

Authors:  Ursula Schlötzer-Schrehardt; Arne Viestenz; Gottfried O H Naumann; Horst Laqua; S Michels; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-08-27       Impact factor: 3.117

View more
  3 in total

Review 1.  The electroretinogram: a useful tool for evaluating age-related macular disease?

Authors:  Emma J Berrow; Hannah E Bartlett; Frank Eperjesi; Jonathan M Gibson
Journal:  Doc Ophthalmol       Date:  2010-03-16       Impact factor: 2.379

2.  Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD.

Authors:  Marilita M Moschos; Dimitrios Brouzas; Michael Apostolopoulos; Chrysanthi Koutsandrea; Eleni Loukianou; Michael Moschos
Journal:  Doc Ophthalmol       Date:  2007-01-10       Impact factor: 2.379

3.  Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity.

Authors:  Beatrix Feigl; Amanda Greaves; Brian Brown
Journal:  Clin Ophthalmol       Date:  2007-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.